HAVCR2 and neoplasm: Upregulation of TIM-3 may be a mechanism of adaptive tumor resistance to therapeutic PD-1 blockade [69] and combinatorial blockade of the PD-1 and TIM-3 pathways could reverse T cell exhaustion and restore anti-tumor immunity [70].